secwatch / observer

Chiron Real Estate Inc. — fact timeline

Source-grounded facts extracted from Chiron Real Estate Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

XRN Chiron Real Estate Inc. JSON
Earnings Releases

Chiron Real Estate Inc. reported nine months ended September 30, 2022 results: revenue $101.0 million, net income $13.0 million, EPS $0.20 per diluted share.

“Net income attributable to common stockholders was $13.0 million, or $0.20 per diluted share, as compared to $8.0 million, or $0.13 per diluted share, in the comparable prior year period. · FFO of $48.6 million, or $0.70 per share and unit, as compared to $42.6 million, or $0.67 per share and unit, in the comparable prior year period. · AFFO of $51.5 million, or $0.74 per share and unit, as compared to $45.0 million, or $0.71 per share and unit, in the comparable prior year period. · Increased total revenue 18.0% year-over-year to $101.0 million, primarily driven by the Company’s acquisition activity.”
Earnings Releases

Chiron Real Estate Inc. reported three months ended September 30, 2022 results: revenue $35.4 million, net income $8.1 million, EPS $0.12 per diluted share.

“Net income attributable to common stockholders was $8.1 million, or $0.12 per diluted share, as compared to $3.7 million, or $0.06 per diluted share, in the comparable prior year period. · Funds from Operations (“FFO”) of $16.2 million, or $0.23 per share and unit, as compared to $15.8 million, or $0.23 per share and unit, in the comparable prior year period. · Adjusted Funds from Operations (“AFFO”) of $17.1 million, or $0.25 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 18.1% year-over-year to $35.4 million, primarily driven by the Company’s acquisition activity.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.